These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3170521)

  • 1. Stability and transformation of the glucocorticoid receptor under acidic conditions.
    Nemoto T; Ohara-Nemoto Y; Ota M
    J Biochem; 1988 Jun; 103(6):920-7. PubMed ID: 3170521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transformed glucocorticoid receptor has a lower steroid-binding affinity than the nontransformed receptor.
    Nemoto T; Ohara-Nemoto Y; Denis M; Gustafsson JA
    Biochemistry; 1990 Feb; 29(7):1880-6. PubMed ID: 2184891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA binding to the untransformed glucocorticoid receptor. Sensitivity to substrate-specific ribonucleases and characterization of a ribonucleic acid associated with the purified receptor.
    Sablonnière B; Economidis IV; Lefebvre P; Place M; Richard C; Formstecher P; Rousseau GG; Dautrevaux M
    Eur J Biochem; 1988 Nov; 177(2):371-82. PubMed ID: 2461303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical characterization of the activated and non-activated forms of the glucocorticoid-receptor complex bound to the steroid antagonist [3H]RU 486.
    Sablonniere B; Danze PM; Formstecher P; Lefebvre P; Dautrevaux M
    J Steroid Biochem; 1986 Nov; 25(5A):605-14. PubMed ID: 3795940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical differences between glucocorticoid-binding components from the corticoid-sensitive and -resistant strains of mouse lymphoma P1798.
    Stevens J; Stevens YW
    Cancer Res; 1979 Oct; 39(10):4011-21. PubMed ID: 476639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that pH induced activation of the rat hepatic glucocorticoid-receptor complex is irreversible.
    Bodine PV; Schmidt TJ; Litwack G
    J Steroid Biochem; 1984 Mar; 20(3):683-9. PubMed ID: 6708546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of an antiserum against the glucocorticoid receptor.
    Okret S; Carlstedt-Duke J; Wrange O; Carlström K; Gustafsson JA
    Biochim Biophys Acta; 1981 Oct; 677(2):205-19. PubMed ID: 7295795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical characterization of the rat kidney glucocorticoid receptor. The role of proteolysis in the formation of corticosteroid binder IB.
    Eisen LP; Harrison RW; Harmon JM
    J Biol Chem; 1986 Mar; 261(8):3725-31. PubMed ID: 3949786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic glucocorticoid receptor behaves differently when its hormone binding site is occupied by agonist (triamcinolone acetonide) or antagonist (RU486) steroid ligands.
    Moudgil VK; Gunda M
    Biochem Biophys Res Commun; 1991 Feb; 174(3):1239-47. PubMed ID: 1996987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of rat liver glucocorticoid receptor with a newly synthesized antisteroid ZK98299.
    Zakula Z; Moudgil VK
    Biochim Biophys Acta; 1991 Apr; 1092(2):188-95. PubMed ID: 2018785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RU 486 stabilizes a high molecular weight form of the glucocorticoid receptor containing the 90K non-steroid binding protein in intact thymus cells.
    Lefebvre P; Formstecher P; Richard C; Dautrevaux M
    Biochem Biophys Res Commun; 1988 Feb; 150(3):1221-9. PubMed ID: 3342067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and changes in the sedimentation properties of rat liver glucocorticoid receptor.
    Alexis MN; Djordević-Marković R; Sekeris CE
    J Steroid Biochem; 1983 Jun; 18(6):655-63. PubMed ID: 6865409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of corticosteroid binder IB with the alpha-chymotrypsin- and RNase-treated hepatic glucocorticoid receptors.
    Mayer M; Schmidt TJ; Miller A; Litwack G
    J Steroid Biochem; 1983 Dec; 19(6):1719-28. PubMed ID: 6672455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical characteristics of the interaction of the glucocorticoid antagonist RU38486 with glucocorticoid receptors in vitro, and the role of molybdate.
    Bell PA; Weatherill PJ
    J Steroid Biochem; 1986 Oct; 25(4):473-81. PubMed ID: 3773520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors.
    Beck CA; Estes PA; Bona BJ; Muro-Cacho CA; Nordeen SK; Edwards DP
    Endocrinology; 1993 Aug; 133(2):728-40. PubMed ID: 8344212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-lapachone, a specific competitive inhibitor of ligand binding to the glucocorticoid receptor.
    Schmidt TJ; Miller-Diener A; Litwack G
    J Biol Chem; 1984 Aug; 259(15):9536-43. PubMed ID: 6746659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogenetiy of glucocorticoid binders: a high affinity triamcinolone acetonide binder in bovine serum.
    Do Y; Feldman D
    Endocrinology; 1980 Nov; 107(5):1370-75. PubMed ID: 6775927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The studies on the loss and recovery of the steroid binding ability of rat liver glucocorticoid receptor].
    Takada Y; Nakao K; Yana S
    Nihon Naibunpi Gakkai Zasshi; 1988 Dec; 64(12):1258-72. PubMed ID: 3248623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triamcinolone acetonide 21-oic acid methyl ester: a potent local antiinflammatory steroid without detectable systemic effects.
    Gorsline J; Bradlow HL; Sherman MR
    Endocrinology; 1985 Jan; 116(1):263-73. PubMed ID: 3855256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical differentiation of type I and type II receptors for adrenal steroids in brain cytosol.
    Emadian SM; Luttge WG; Densmore CL
    J Steroid Biochem; 1986 May; 24(5):953-61. PubMed ID: 2425155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.